申请人:Chiesi Farmaceutici S.p.A.
公开号:US04775676A1
公开(公告)日:1988-10-04
Compounds of formula I ##STR1## wherein A represents: a saturated or unsaturated acyclic residue; a saturated cyclic or heterocyclic residue; a saturated or unsaturated bicyclic residue; and R represents OH, a C.sub.1 -C.sub.4 alkoxy group or a straight or heterocycle aminoresidue; R.sub.1 represents hydrogen, an alkyl group or an aromatic or heteroaromatic residue. Compounds I are endowed with valuable therapeutic characteristics.
式I的化合物,其中A代表:饱和或不饱和的无环残基;饱和的环状或杂环残基;饱和或不饱和的双环残基;R代表OH,C.sub.1 -C.sub.4烷氧基团或直链或杂环氨基残基;R.sub.1代表氢,烷基团或芳香或杂芳香残基。化合物I具有宝贵的治疗特性。